Volume 134, Issue 5, Pages (May 2008)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 141, Issue 5, Pages e1 (November 2011)
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells  Sugiko Watanabe, Yasuaki Ueda, Shin-ichi Akaboshi,
Cell Physiol Biochem 2017;44:1867– DOI: /
Volume 131, Issue 4, Pages (October 2006)
Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel- Associated Mural Cells  Sven Christian, Renate Winkler, Iris Helfrich,
Volume 146, Issue 5, Pages (May 2014)
Volume 144, Issue 5, Pages e10 (May 2013)
Volume 15, Issue 6, Pages (June 2012)
Volume 132, Issue 5, Pages (May 2007)
Volume 138, Issue 3, Pages e2 (March 2010)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 133, Issue 1, Pages (July 2007)
Volume 36, Issue 5, Pages (December 2009)
Volume 127, Issue 2, Pages (August 2004)
Volume 55, Issue 1, Pages (July 2014)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 5, Pages e1 (November 2011)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 144, Issue 2, Pages (February 2013)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 136, Issue 5, Pages (May 2009)
Volume 5, Issue 5, Pages (May 2004)
Volume 134, Issue 7, Pages (June 2008)
Volume 139, Issue 6, Pages (December 2010)
Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity  Jing Xue, Xuebing Li, Shi Jiao,
Volume 19, Issue 2, Pages (February 2017)
Volume 76, Issue 1, Pages (July 2009)
Volume 141, Issue 6, Pages (December 2011)
Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma  Antonio Mazzocca, Francesco Liotta,
Volume 142, Issue 3, Pages (March 2012)
Volume 134, Issue 1, Pages (January 2008)
Volume 132, Issue 5, Pages (May 2007)
Volume 140, Issue 5, Pages (May 2011)
Volume 136, Issue 5, Pages (May 2009)
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 146, Issue 5, Pages (May 2014)
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 142, Issue 2, Pages e5 (February 2012)
Volume 132, Issue 2, Pages (February 2007)
Volume 137, Issue 4, Pages (October 2009)
Volume 147, Issue 5, Pages (November 2014)
Volume 19, Issue 3, Pages (March 2017)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 133, Issue 6, Pages (December 2007)
Volume 22, Issue 10, Pages (October 2014)
Volume 140, Issue 3, Pages (March 2011)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 136, Issue 3, Pages e2 (March 2009)
Wnt5A Activates the Calpain-Mediated Cleavage of Filamin A
Volume 133, Issue 3, Pages (September 2007)
Volume 147, Issue 5, Pages (November 2014)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 137, Issue 6, Pages e5 (December 2009)
Reciprocal Regulation of Thymus and Activation-Regulated Chemokine/Macrophage- Derived Chemokine Production by Interleukin (IL)-4/IL-13 and Interferon-γ.
Volume 2, Issue 6, Pages (December 2012)
Molecular Therapy - Nucleic Acids
Regulation of Wnt Signaling by the Nuclear Pore Complex
Volume 36, Issue 2, Pages (October 2009)
Volume 123, Issue 6, Pages (December 2002)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Volume 136, Issue 5, Pages (May 2009)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
This month in Gastroenterology
Volume 55, Issue 1, Pages (July 2014)
Presentation transcript:

Volume 134, Issue 5, Pages 1555-1566 (May 2008) Polysialylated NCAM Represses E-Cadherin-Mediated Cell-Cell Adhesion in Pancreatic Tumor Cells  Susanne C. Schreiber, Klaudia Giehl, Caroline Kastilan, Cornelia Hasel, Martina Mühlenhoff, Guido Adler, Doris Wedlich, Andre Menke  Gastroenterology  Volume 134, Issue 5, Pages 1555-1566 (May 2008) DOI: 10.1053/j.gastro.2008.02.023 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 NCAM and ST8Sia-II/IV expression in pancreatic carcinomas. (A) mRNA concentration of NCAM was increased in 8 out of 12 samples of pancreatic carcinomas, expression of ST8Sia-II in 10 out of 12 samples, and of ST8Sia-IV in 8 out of 12 samples. The postsurgical histopathologic pTNM classification and stage grouping are shown in Supplemental Table T1 (see Supplementary Table T1 online at www.gastrojournal.org). (B) Three out of 5 pancreatic carcinoma cell lines exhibited expression of NCAM mRNA, and most carcinoma cell lines showed expression of ST8Sia-II/IV mRNA. NCAM protein was detected in the NCAM-mRNA positive cell lines after immunoprecipitation of NCAM from 200 μg cell lysate. PSA was detected after restaining of the blot with a PSA-specific antibody (lower panel). (C) Immunohistochemical analyses of NCAM and PSA localization in IMIM-PC1, BxPC-3, and AsPC-1 pancreatic carcinoma cells using NCAM- and PSA-specific antibodies. Bar, 15 μm. (D) In protein lysates from PANC-1 cells stably expressing EGFP-K-Ras(V12), EGFP-K-Ras(N17), EGFP-H-Ras, or EGFP-N-Ras(V12), only K-Ras(V12)-expressing cells exhibit increased NCAM-expression. Gastroenterology 2008 134, 1555-1566DOI: (10.1053/j.gastro.2008.02.023) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Polysialylated NCAM is up-regulated by K-Ras(V12). (A and B) PANC-1 and HEK293 cells stably expressing EGFP-K-Ras(V12) show elevated concentration of PSA-NCAM. Two different K-Ras(V12)-expressing PANC-1 and HEK293 cell clones were included, and 50 μg total protein lysate were analyzed using NCAM- and PSA-specific antibodies. (C and D) Expression of K-Ras(V12) resulted in elevated NCAM, ST8Sia-II, and ST8Sia-IV mRNA concentrations in PANC-1 and HEK293 cell clones. Amplification of GAPDH mRNA served as control. (E and F) Endo-N treatment of AsPC-1 and PANC-1-K-Ras(V12) cells removed PSA from NCAM as shown by PSA staining. SH-SY5Y neuroblastoma cells served as positive control. Gastroenterology 2008 134, 1555-1566DOI: (10.1053/j.gastro.2008.02.023) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Membrane localization of PSA-NCAM correlates with enhanced cell migration. (A) NCAM and PSA are localized at the cell membrane of K-Ras(V12)-expressing PANC-1 cells by confocal microscopy. The second and fourth panels show overlays of NCAM or PSA staining (red) with EGFP staining (green). Bar, 15 μm. (B) Transwell migration assays revealed an enhanced migration of K-Ras(V12)-expressing PANC-1 cells. (C) Cell aggregation of K-Ras(V12)-expressing, NCAM-positive PANC-1 cells was reduced compared with EGFP-transfected cells. Cadherin dependence was measured by addition of EDTA and EGTA (E+E). Data: Means ± SEM. Gastroenterology 2008 134, 1555-1566DOI: (10.1053/j.gastro.2008.02.023) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 PSA-NCAM interacts with the E-cadherin adhesion complex. (A) NCAM was coimmunoprecipitated with E-cadherin from 3 mg PANC-1-K-Ras(V12) lysates. The blot was restained for E-cadherin. (B) Coimmunoprecipitation assays with lysates from endo-N-treated cells show that E-cadherin was not coprecipitated with NCAM in the absence of PSA. The blots were restained for NCAM. (C) Knock down of NCAM, ST8Sia-II/IV, or of both by specific siRNAs resulted in reduced amounts of polysialylated NCAM in PANC-1-K-Ras(V12) lysates. The blot was restained for β-actin to confirm equal loading. (D) Knock down of NCAM, ST8Sia-II/IV, or both reduced the amount of E-cadherin coimmunoprecipitated with NCAM from 3 mg lysate. Blots were restained for NCAM and PSA to prove the knock down. (E) PSA-NCAM was coimmunoprecipitation with E-cadherin from AsPC-1 lysates. Removal of PSA by endo-N-treatment or siRNA transfection strongly reduced the binding of the NCAM to E-cadherin. Gastroenterology 2008 134, 1555-1566DOI: (10.1053/j.gastro.2008.02.023) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 PSA-NCAM is responsible for low cell-cell aggregation. (A) Cell-cell aggregation assays were performed with EGFP- and EGFP-K-Ras(V12)-expressing cells after treatment with endo-N (+) or buffer only (−). Removal of PSA from NCAM restores E-cadherin-mediated cell-cell adhesion in K-Ras(V12)-expressing cells. The involvement of E-cadherin was determined by addition of inhibitory E-cadherin antibody (shaded bars) and by addition of EDTA and EGTA (open bars). (B) Down-regulated expression of NCAM (shaded bars) or ST8Sia-II/IV (open bars) by siRNA revealed up-regulation of cell-cell aggregation in PANC-1-K-Ras(V12) cells (left graph). Cell migration was reduced in NCAM- or ST8Sia-II/IV-siRNA transfected cells as estimated by transwell migration assays (right graph). (C) Cell-cell aggregation capacity of AsPC-1 cells was increased after transfection with NCAM or ST8Sia-II/IV siRNAs. The involvement of E-cadherin was determined by addition of inhibitory E-cadherin antibody (light gray). All data are means ± SEM of 3 independent assays. Gastroenterology 2008 134, 1555-1566DOI: (10.1053/j.gastro.2008.02.023) Copyright © 2008 AGA Institute Terms and Conditions